CINDY CAMPBELL: Open Payments
NPI 1245795541 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,287 in 74 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,239 · 2025 $1,287
Food & beverage: $1,287
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $193 |
| Novo Nordisk Inc | 12 | $185 |
| Lundbeck LLC | 10 | $170 |
| ABBVIE INC. | 12 | $160 |
| Corium, LLC | 4 | $87 |
| PFIZER INC. | 4 | $82 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $79 |
| GlaxoSmithKline, LLC. | 3 | $56 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
Products named: REXULTI, VRAYLAR, AIRSUPRA, BREZTRI, Azstarys, Wegovy, Kerendia, Ozempic.
Industry payments across AL — which companies pay providers there.
